Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
If the layoff rate remains constant, one could expect 252 workforce reductions by the end of the year—a 27% percentage point jump from 2024.
Gabrielle Masson
Oct 3, 2025 4:30pm
Sponsored
How to get pharmaceutical treatments where they’re needed most.
Oct 6, 2025 8:00am
Novo vs. KBP Chapter 2: 'Anomalous' trial results
Oct 2, 2025 3:00am
Sponsored
Accelerate clinical trials with a connected financial ecosystem
Oct 6, 2025 8:00am
Fierce Biotech Layoff Tracker 2025: Pharming, Bolt & more
Oct 6, 2025 1:30pm
TCG Crossover hauls in $1.3B for third investment fund
Oct 6, 2025 11:14am
More News
AstraZeneca, Algen Biotechnologies pen $555M AI pact
Oct 6, 2025 8:00am
Skye's CB1 blocker fails to reduce weight in obesity study
Oct 6, 2025 7:55am
3 scientists win Nobel Prize for discovery of regulatory T cells
Oct 6, 2025 7:03am
Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal
Oct 6, 2025 7:00am
See more stories